JONATHAN KELBER
I received my BS/MS in chemistry from Cal Poly Pomona, where I conducted research in biophysics under the mentoring of Dr. Patrick Mobley. I received my PhD in biochemistry from UCSD and studied TGFbeta signaling with Wylie Vale at the Salk Institute. I completed an NIH-IRACDA postdoctoral fellowship with Richard Klemke at UCSD and identified the PEAK1 pseudokinase as driver of cancer progression. I am currently a full professor of biology at Cal State Northridge and direct the NIH-funded Developmental Oncogene Laboratory that aims to understand mechanisms controlling cell state plasticity and proliferation during cancer progression and tissue regeneration. I was a 2013 ASBMB grant writing scholar, a 2014 ASCB-MAC FRED program participant, a 2017 ASCB-MAC visiting professor with Joan Brugge's group at the Harvard Medical School Ludwig Center, the 2019/20 US-UK Fulbright-CRUK fellow with Martin Humphries' group at the University of Manchester and the 2021 CSUPERB Faculty Research Awardee. I am an Member on the ASCB MAC, serve on the Cal State Northridge Institutional Review Board (IRB) and a member of the NIH Tumor Evolution Heterogeneity and Metastasis (TEHM) study section. I enjoy spending time with family/friends, playing music, serving my church community and playing sports.
